NRG3
Basic information
Region (hg38): 10:81875194-82987179
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NRG3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 34 | 39 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 34 | 3 | 7 |
Variants in NRG3
This is a list of pathogenic ClinVar variants found in the NRG3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-81875413-A-T | not specified | Uncertain significance (Aug 04, 2021) | ||
10-81875426-C-A | not specified | Uncertain significance (Mar 01, 2023) | ||
10-81875485-C-T | not specified | Uncertain significance (Dec 16, 2023) | ||
10-81875492-A-T | not specified | Uncertain significance (Aug 04, 2023) | ||
10-81875515-G-A | not specified | Uncertain significance (Jun 01, 2023) | ||
10-81875624-A-G | not specified | Uncertain significance (Dec 05, 2022) | ||
10-81875637-C-T | Benign (Mar 29, 2018) | |||
10-81875651-A-G | not specified | Uncertain significance (Feb 05, 2024) | ||
10-81875663-T-G | not specified | Uncertain significance (Apr 06, 2022) | ||
10-81875732-C-G | not specified | Uncertain significance (May 09, 2022) | ||
10-81875865-C-G | not specified | Uncertain significance (Aug 02, 2021) | ||
10-81875870-C-G | not specified | Uncertain significance (May 09, 2024) | ||
10-81875891-C-T | not specified | Uncertain significance (Aug 29, 2022) | ||
10-81875893-C-G | not specified | Uncertain significance (Aug 17, 2022) | ||
10-81875968-C-T | not specified | Uncertain significance (May 30, 2024) | ||
10-81875974-G-C | not specified | Uncertain significance (Apr 07, 2023) | ||
10-81875981-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
10-81876001-A-G | not specified | Uncertain significance (Oct 12, 2021) | ||
10-81876028-G-T | not specified | Uncertain significance (Oct 18, 2021) | ||
10-81876031-A-G | not specified | Uncertain significance (Oct 26, 2021) | ||
10-81876041-A-T | not specified | Uncertain significance (Apr 07, 2023) | ||
10-81876042-C-T | Benign (Jul 19, 2018) | |||
10-81876058-C-G | not specified | Uncertain significance (Nov 18, 2022) | ||
10-81876136-C-G | not specified | Uncertain significance (Jan 29, 2024) | ||
10-81878019-C-G | Aganglionic megacolon | Uncertain significance (May 16, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NRG3 | protein_coding | protein_coding | ENST00000372141 | 9 | 1111866 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.109 | 0.891 | 125677 | 0 | 71 | 125748 | 0.000282 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.257 | 385 | 371 | 1.04 | 0.0000187 | 4473 |
Missense in Polyphen | 124 | 152.48 | 0.81323 | 1770 | ||
Synonymous | -1.04 | 171 | 155 | 1.11 | 0.00000833 | 1464 |
Loss of Function | 3.85 | 8 | 31.2 | 0.256 | 0.00000189 | 329 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000340 | 0.000337 |
Ashkenazi Jewish | 0.00199 | 0.00199 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000247 | 0.000246 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.000261 | 0.000261 |
Other | 0.000490 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Direct ligand for the ERBB4 tyrosine kinase receptor. Binding results in ligand-stimulated tyrosine phosphorylation and activation of the receptor. Does not bind to the EGF receptor, ERBB2 or ERBB3 receptors. May be a survival factor for oligodendrocytes. {ECO:0000269|PubMed:16478787, ECO:0000269|PubMed:9275162}.;
- Pathway
- ErbB signaling pathway - Homo sapiens (human);EGFR Inhibitor Pathway, Pharmacodynamics;EGF-Core;ErbB Signaling Pathway;SHC1 events in ERBB2 signaling;Signaling by PTK6;Disease;Signal Transduction;neuroregulin receptor degredation protein-1 controls erbb3 receptor recycling;g-secretase mediated erbb4 signaling pathway;ERBB2 Activates PTK6 Signaling;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;GPCR signaling-G alpha s Epac and ERK;Downregulation of ERBB2 signaling;GPCR signaling-G alpha s PKA and ERK;agrin in postsynaptic differentiation;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades;PIP3 activates AKT signaling;GRB2 events in ERBB2 signaling;Signaling by Non-Receptor Tyrosine Kinases;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Negative regulation of the PI3K/AKT network;Constitutive Signaling by Aberrant PI3K in Cancer;PI3K events in ERBB2 signaling;Signaling by ERBB2;ERBB2 Regulates Cell Motility;SHC1 events in ERBB4 signaling;PI3K/AKT Signaling in Cancer;PI3K events in ERBB4 signaling;GPCR signaling-G alpha i;Nuclear signaling by ERBB4;Signaling by ERBB4;Signaling by Receptor Tyrosine Kinases;Intracellular signaling by second messengers;Diseases of signal transduction;ErbB receptor signaling network
(Consensus)
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.580
- rvis_EVS
- -0.46
- rvis_percentile_EVS
- 23.57
Haploinsufficiency Scores
- pHI
- 0.157
- hipred
- Y
- hipred_score
- 0.655
- ghis
- 0.581
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.639
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nrg3
- Phenotype
- endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- regulation of cell growth;activation of transmembrane receptor protein tyrosine kinase activity;pattern specification process;regulation of signaling receptor activity;chemorepulsion involved in interneuron migration from the subpallium to the cortex;intracellular signal transduction;modulation of chemical synaptic transmission;mammary placode formation;negative regulation of neuron migration
- Cellular component
- extracellular region;extracellular space;integral component of plasma membrane;glutamatergic synapse
- Molecular function
- signaling receptor binding;growth factor activity;transmembrane receptor protein tyrosine kinase activator activity;receptor tyrosine kinase binding;chemorepellent activity